Alan Bash
Interim CEO at Legend Biotech Corp (LEGN) since July 2026
Alan Bash has filed 5 insider reports with the SEC since March 2022, as interim CEO at Legend Biotech Corp (LEGN) and officer and director at Checkmate Pharmaceuticals, Inc. (CMPI). The latest filing, on August 18, 2026, reports grant or award at Legend Biotech Corp (LEGN).
- Filings
- 5
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Alan Bash is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech Corp | Interim CEOsince July 2026 | 35,142 | $23.40 | Aug 18, 2026 | |||
| CMPI Checkmate Pharmaceuticals, Inc. | Officer, Directorsince March 2022 | May 31, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 14, 2026LEGNInterim CEO Bash Alan was granted 4,908 units of Ordinary Shares, increasing direct ownership by 16% to 35,142 unitsForm 4Grant or award
- Jul 24, 2026LEGNNew insider Bash Alan claimed ownership of 30,234 units of Ordinary SharesForm 3New insider
- May 31, 2022CMPISEC Form 4 filed by Bash AlanForm 4Sale back to the company
- Mar 1, 2022CMPISEC Form 4 filed by Bash AlanForm 4Grant or award
- Mar 1, 2022CMPIAlan Bash became an insiderForm 3New insider
Compare Alan Bash with
- Alan Bash vs Sanders Corazon (Corsee) D.1 shared
- Alan Bash vs Tomas J. Heyman1 shared
- Alan Bash vs Patrick John Casey1 shared
- Alan Bash vs Li Mao1 shared
- Alan Bash vs Darren Xiaohui Ji1 shared
- Alan Bash vs Peter Salovey1 shared
Other insiders at the same companies
- Sanders Corazon (Corsee) D.LEGN
- Darren Xiaohui JiLEGN
- Li MaoLEGN
- Patrick John CaseyLEGN
- Peter SaloveyLEGN
- Tomas J. HeymanLEGN
- Carlos E SantosLEGN
- Ingrid ZhangLEGN
- Ying HuangLEGN
- Robin MengLEGN
- Gareth KungLEGN
- Fangliang ZhangLEGN
- Ye WangLEGN
Questions about Alan Bash
- What is Alan Bash's role at Legend Biotech Corp?
- Alan Bash reports to the SEC as interim CEO at Legend Biotech Corp (LEGN), according to the latest filing on August 18, 2026. Alan Bash has also filed as officer and director at Checkmate Pharmaceuticals, Inc. (CMPI).
- How many shares does Alan Bash own?
- After the latest filing that states it, Alan Bash directly owned 35,142 shares of Legend Biotech Corp (LEGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Alan Bash bought or sold stock recently?
- No open-market purchases or sales by Alan Bash are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Alan Bash files?
- Follow Alan Bash on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Alan Bash filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Alan Bash (SEC CIK 0001908421). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2022 on. View on SEC EDGAR